(1)
Detection and Assessment of Drug-Related Problems Associated With Dapagliflozin in Patients With Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study. Int. J. Pharm. Sci. Lett. 2026, 16 (1), 01-04.